![]()
|
Report Date : |
20.09.2008 |
IDENTIFICATION
DETAILS
|
Name : |
RANTUS PHARMA PRIVATE LIMITED |
|
|
|
|
Registered Office : |
401, Surya Teja Apartments, Dharmareddy Colony, Kukatpally, Hyderabad
– 500072, Andhra Pradesh. |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as on) : |
31.03.2007 |
|
|
|
|
Date of Incorporation : |
07.02.2003 |
|
|
|
|
Com. Reg. No.: |
40459 |
|
|
|
|
CIN No.: [Company
Identification No.] |
U24239AP2003PTC040459 |
|
|
|
|
TAN No.: [Tax
Deduction & Collection Account No.] |
HYDR02310A |
|
|
|
|
PAN No.: [Permanent
Account No.] |
AACCR3767N |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business : |
Manufacturer of Pharmaceuticals Ingredients. |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 122000 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Usually Correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a well established company having satisfactory track.
Directors are reported as experienced, respectable and resourceful
businessmen. Their trade relations are fair. Payments are usually correct and
as per commitments. The concern can be considered good for normal business dealings at
usual trade terms and conditions. |
INFORMATION PARTED
BY
|
Name : |
Mr. Krishna Reddy |
|
Designation : |
Account Department |
|
Date : |
06.09.2008 |
LOCATIONS
|
Registered Office : |
401, Surya Teja Apartments, Dharmareddy Colony, Kukatpally, Hyderabad
– 500072, Andhra Pradesh, India |
|
E-Mail : |
|
|
Website : |
|
|
Area : |
1000 sq ft |
|
Location : |
Owned |
|
|
|
|
Factory : |
Flat No. 215, Bhanu Enclave, Erragadda, Hyderabad – 500038, Andhra
Pradesh, India |
|
Tel. No.: |
91-40-23818293 91-40-23706123 (Marketing Department) |
|
Fax No.: |
91-40-23810649 |
|
E-Mail : |
|
|
Area : |
900 sq ft |
|
Location : |
Rented |
|
|
|
|
Factory 2 : |
Plot No.29/ DA Phase 2, Pasany Loram
39, Patahcheru, Andhra Pradesh |
|
Tel No.: |
91-8455-225515 |
|
Area : |
2 Acers |
|
Location : |
Owned |
DIRECTORS
|
Name : |
Mr. K Umamaheswara Rao |
|
Designation : |
Managing Director |
|
Address : |
Flat No.410, Surya Teja Apartments, Dharmareddy Colony, Kukatpally, Hyderabad
– 500072, Andhra Pradesh, India |
|
Date of Birth/Age : |
30.07.1962 |
|
Qualification : |
BSC |
|
Date of Appointment : |
17.06.2003 |
|
|
|
|
Name : |
Mr. K Ratnakumari |
|
Designation : |
Director |
|
Address : |
Flat No.410, Surya Teja Apartments, Dharmareddy Colony, Kukatpally,
Hyderabad – 500072, Andhra Pradesh, India |
|
Date of Birth/Age : |
13.06.1967 |
|
Qualification : |
B.Com |
|
Date of Appointment : |
17.02.2003 |
|
|
|
|
Name : |
Mr. N Soudhamani |
|
Designation : |
Director |
|
Address : |
24- 110, Kakathiya nagar, road no.3, Ashok Nagar, Hyderabad – 500032,
Andhra Pradesh |
|
Date of Birth/Age : |
13.06.1967 |
|
Qualification : |
B.Com |
|
Date of Appointment : |
17.02.2003 |
|
|
|
|
Name : |
Mr. Udadagiri Tata Rao |
|
Designation : |
Director |
|
Address : |
F. No.501, Sree Maruthi Heights, Sanjeeva Reddy Nagar, Hyderabad-
500038, Andhra Pradesh |
|
Date of Birth/Age : |
13.06.1960 |
|
Date of Appointment : |
07.02.2003 |
|
|
|
|
Name : |
Mr. Sundera Pullaiah Naidu |
|
Designation : |
Director |
|
Address : |
F. no.101, rukmini Enclave, Dharamkaram Road, Ameerpet, Hydearbad –
500038, Andhra Pradesh. |
|
Date of Birth/Age : |
1.01.1960 |
|
Date of Appointment : |
07.02.2003 |
KEY EXECUTIVES
|
Name : |
Ravi and Subramanyam |
|
Designation : |
Company Secretary |
|
Address : |
H. No. 5-9-71/22/B, MCH No.250, Opposite to Darpan Boutique Adarsh
Nagar, Near Birla Mandir, Hyderabad – 500063 |
|
Phone No.: |
91-40-23242325/ 23242326 |
MAJOR SHAREHOLDERS
/ SHAREHOLDING PATTERN
AS ON 29.09.2007
|
Names of Shareholders |
|
No. of Shares |
|
Mr. K Umamaheswara Rao |
|
208815 |
|
Mr. K Ratnakumari |
|
362685 |
|
Mr. N Soudhamani |
|
178500 |
|
Total |
|
750000 |
AS ON 29.09.2007
|
Equity Share
Breakup |
|
Percentage of
Holding |
|
Category |
|
|
|
Directors or relatives of directors |
|
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer of Pharmaceuticals Ingredients. |
|
|
|
|
Product : |
· APIs ·
Intermediates |
|
|
|
|
Exports : |
|
|
Products : |
Pharmaceuticals Products |
|
Countries : |
Hong Kong, Pakistan |
|
|
|
|
Imports : |
|
|
Countries : |
China |
|
|
|
|
Terms : |
|
|
Selling : |
L/C and T/T |
|
|
|
|
Purchasing : |
L/C and T/T |
GENERAL
INFORMATION
|
No. of Employees : |
75 (office – 15, Factory - 60) |
|
|
|
|
Bankers : |
UCO Bank, Banjara Hill Branch |
|
|
|
|
Facilities : |
CC Limit Rs.15.000 Millions and L/C Rs.15.000 Millions |
|
|
|
|
Banking
Relations : |
Satisfactory |
|
|
|
|
Auditors : |
|
|
Name : |
Ramanatham and Company Mr. C Kameswara Rao Chartered Accountant |
|
Membership No.: |
24363 |
|
Address : |
302, Kalamansion, S D Road, P B No. 2102, Secunderabad 500003 |
|
Tel. No.: |
91-40-27814147 |
|
Fax No.: |
91-40-27840307 |
|
|
|
|
Sister Consist : |
Alekha Durga Private Limited |
|
Address : |
Andhra Pradesh |
CAPITAL STRUCTURE
AS ON 29.09.2007
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
1000000 |
Equity Shares |
Rs. 10/- Each |
Rs.10.000
Millions |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
750000 |
Equity Shares |
Rs. 10/- Each |
Rs.7.500 Millions |
FINANCIAL DATA
[all figures are in Rupees Millions]
|
Particulars |
|
|
31.03.2008 |
|
Sales Turnover |
|
|
220.000 |
Expected Sales (2008-09) : Rs.300.000 Millions
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2007 |
31.03.2006 |
31.03.2005 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
7.500 |
0.100 |
0.100 |
|
|
2] Share Application Money |
0.918 |
8.248 |
7.400 |
|
|
3] Reserves & Surplus |
15.982 |
5.640 |
1.182 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
24.400 |
13.988 |
8.682 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
17.978 |
13.407 |
9.252 |
|
|
2] Unsecured Loans |
18.680 |
22.335 |
5.413 |
|
|
TOTAL BORROWING |
36.658 |
35.742 |
14.665 |
|
|
DEFERRED TAX LIABILITIES |
1.346 |
0.818 |
0.299 |
|
|
|
|
|
|
|
|
TOTAL |
62.404 |
50.548 |
23.647 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
31.405 |
21.939 |
16.884 |
|
|
Capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
5.830 |
0.000 |
0.000 |
|
|
DEFERREX TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
23.660
|
14.107 |
16.529 |
|
|
Sundry Debtors |
67.098
|
57.955 |
16.801 |
|
|
Cash & Bank Balances |
6.186
|
1.301 |
0.706 |
|
|
Other Current Assets |
2.520
|
6.220 |
4.234 |
|
|
Loans & Advances |
1.104
|
3.103 |
0.353 |
|
Total
Current Assets |
100.568
|
82.686 |
38.623 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Current Liabilities |
74.034
|
53.180 |
31.571 |
|
|
Provisions |
1.732
|
0.908 |
0.304 |
|
Total
Current Liabilities |
75.766
|
54.088 |
31.875 |
|
|
Net Current Assets |
24.802
|
28.598 |
6.747 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.006 |
0.010 |
0.015 |
|
|
|
|
|
|
|
|
TOTAL |
62.404 |
50.548 |
23.647 |
|
PROFIT & LOSS
ACCOUNT
|
PARTICULARS |
31.03.2007 |
31.03.2006 |
31.03.2005 |
|
|
Sales Turnover |
214.785 |
166.072 |
58.028 |
|
|
Job Work |
7.372 |
2.859 |
2.220 |
|
|
Other Income |
0.078 |
0.363 |
0.005 |
|
|
Total Income |
222.235 |
169.294 |
60.253 |
|
|
|
|
|
|
|
|
Profit/(Loss) Before Tax |
13.947 |
5.976 |
0.997 |
|
|
Provision for Taxation |
2.855 |
1.519 |
1.367 |
|
|
Profit/(Loss) After Tax |
11.092 |
4.457 |
0.729 |
|
|
|
|
|
|
|
|
Export Value |
10.037 |
9.493 |
0.825 |
|
|
|
|
|
|
|
|
Expenditures : |
|
|
|
|
|
|
Administrative Expenses |
1.974 |
1.746 |
0.735 |
|
|
Increase/(Decrease) in Finished Goods |
8.143 |
(0.271) |
4.404 |
|
|
Depreciation & Amortization |
1.408 |
0.845 |
0.573 |
|
|
Other Expenditure |
196.763 |
160.998 |
53.544 |
|
Total Expenditure |
208.288 |
163.318 |
59.256 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2007 |
31.03.2006 |
31.03.2005 |
|
PAT / Total Income |
(%) |
04.99
|
02.63 |
01.20 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
06.49
|
03.59 |
01.71 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
10.12
|
05.71 |
01.79 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
57.15
|
42.72 |
11.48 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
4.60
|
6.42 |
5.36 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.32
|
1.52 |
1.21 |
LOCAL AGENCY
FURTHER INFORMATION
Trade Reference
·
Cipla
·
Cadila
·
Epka
FORM NO.8
|
This form is for |
Creation of
charge |
||||||
|
Corporate
identity number of the company |
U24239AP2003PTC040459 |
||||||
|
Name of the
company |
RANTUS PHARMA
PRIVATE LIMITED |
||||||
|
Address of the
registered office or of the principal place of business in India of the company |
401, Surya Teja Apartments, Dharmareddy Colony, Kukatpally, Hyderabad
– 500072, Andhra Pradesh. |
||||||
|
Type of charge |
Immovable
Property Others |
||||||
|
Particular of
charge holder |
|
||||||
|
Nature of
description of the instrument creating or modifying the charge |
Corporate
Guarantee Memorandum of
deposit of title deed |
||||||
|
Date of
instrument Creating the charge |
29.03.2007 |
||||||
|
Amount secured by
the charge |
Rs.70.000
Millions |
||||||
|
Short particulars
of the property charged |
Land admeasuring 5.125
Acers situated at Tangadapally, Choutuppal – Nalgonda District |
|
Name of the company |
RANTUS PHARMA
PRIVATE LIMITED |
|
Presented By |
K. Umamaheswara
Rao Private Limited |
|
1) Date and description of instrument creating the change |
·
Hypothecation
of goods to secured demand cash credit ·
Hypothecation
and book debts to secure demand cash credit ·
Agreement
for extension of charge by way of hypothecation over current assets to
secured non fund based facilities All dated
14.02.2005 |
|
2) Amount secured by the charge/amount owing on the securities of charge |
Rs.10.000
Millions for cash credit Rs.5.000 Millions
for letter of credit Agreement to
Rs.15.000 millions |
|
3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given |
Hypothecation of
stocks debtor and other current assets and Plant and Machinery |
|
4) Gist of the terms and conditions and extent and operation of the charge. |
Interest rate of
2% p.a. above the deposit rate/ UCO bank prime lending rate which is at
present 11% p.a. subject to minimum rate of interest of 13% p.a. or at such
other rate as may be denied by UCO Bank from time to time under intimation
with monthly rests for value received. |
|
5) Name and Address and description of the person entitled to the charge. |
UCO Bank, M.G.
Road Branch, Secunderabad |
|
6) Date and brief description of instrument modifying the charge |
NA |
WEB DETAILS ATTACHED
Commitment
to quality in everything they do, innovation and continuous improvement,
collaboration and teamwork, harmony and social responsibility. Their business
practices are guided by ethics, honesty, and transparency.
They
will endeavour to achieve the highest standards in their Production and Quality
to delight their customers.
Subject
manufactures high-quality Active Pharmaceutical Ingredients (APIs)
and Intermediates. They have their state-of-the-art
manufacturing facilities at IDA Pasamailaram near Hyderabad,
Andhra Pradesh, India.
Their
primary objective is to achieve highest customer satisfaction
by supplying high-quality APIs and Intermediates to meet their requirements.
Their
quest has been to sustain and improve the quality of APIs and Intermediates.
They
have 20 Stainless Steel Reactors and 4 Glass Lined Reactors, and have plans to
expand their infrastructure considerably. They have the capacity to produce in
excess of 10 Tons of APIs and Intermediates per month.
DISCLAIMER:
CMT REPORT
(Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts, India Prisons Service,
Interpol, etc.
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners, controlling
shareholders or senior officers as terrorist or terrorist organization or whom
notice had been received that all financial transactions involving their assets
have been blocked or convicted, found guilty or against whom a judgement or
order had been entered in a proceedings for violating money-laundering,
anti-corruption or bribery or international economic or anti-terrorism sanction
laws or whose assets were seized, blocked, frozen or ordered forfeited for
violation of money laundering or international anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper payments
to government officials for engaging in prohibited transactions or with
designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l Anti-Money
Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals have
been formally charged or convicted by a competent governmental authority for
any financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE
GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.46.32 |
|
UK Pound |
1 |
Rs.83.57 |
|
Euro |
1 |
Rs.65.90 |
SCORE & RATING
EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
6 |
|
PAID-UP CAPITAL |
1~10 |
6 |
|
OPERATING SCALE |
1~10 |
6 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
6 |
|
--PROFITABILIRY |
1~10 |
6 |
|
--LIQUIDITY |
1~10 |
6 |
|
--LEVERAGE |
1~10 |
6 |
|
--RESERVES |
1~10 |
6 |
|
--CREDIT LINES |
1~10 |
6 |
|
--MARGINS |
-5~5 |
- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
54 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|